Functions of Coenzyme Q10 Supplementation on Liver Enzymes, Markers of Systemic Inflammation, and Adipokines in Patients Affected by Nonalcoholic Fatty Liver Disease: A Double-Blind, Placebo-Controlled, Randomized Clinical Trial-Reference-Cited by-同舟云学术

Functions of Coenzyme Q10 Supplementation on Liver Enzymes, Markers of Systemic Inflammation, and Adipokines in Patients Affected by Nonalcoholic Fatty Liver Disease: A Double-Blind, Placebo-Controlled, Randomized Clinical Trial

Published:2015-07-09 Issue:4 Volume:35 Page:346-353
ISSN:0731-5724
Container-title:Journal of the American College of Nutrition
language:en
Short-container-title:Journal of the American College of Nutrition

Author:

Farsi Farnaz,Mohammadshahi Majid,Alavinejad Pezhman,Rezazadeh Afshin,Zarei Mehdi,Engali Kambiz Ahmadi

Publisher

Informa UK Limited

Subject

Nutrition and Dietetics,Medicine (miscellaneous)

Link

http://www.tandfonline.com/doi/pdf/10.1080/07315724.2015.1021057

Reference43 articles.

1. Adipokines and cytokines in non-alcoholic fatty liver disease

2. Prevalence of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis Among a Largely Middle-Aged Population Utilizing Ultrasound and Liver Biopsy: A Prospective Study

3. Obesity as the common soil of non-alcoholic fatty liver disease and diabetes: Role of adipokines

4. Fundamento molecular de la esteatosis hepática asociada a la obesidad

Cited by 95 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Co-enzyme-Q10 and taurine abate isoprenaline-mediated hepatorenal dysregulations and oxidative stress in rats;Clinical Nutrition Open Science;2024-10

2. Potential Chemotherapeutic Effect of Coenzyme Q10 Against Liver Injury in a Leukemia Rat Model by 7,12-Dimethylbenz[a]anthracene;International Journal of Pharmacology;2024-09-15

3. Use of a Micronutrient Cocktail to Improve Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) in Adults with Obesity: A Randomized, Double-Blinded Pilot Clinical Trial;Medicina;2024-08-21

4. The Role of Coenzyme Q10 Supplementation in the Treatment of Diabetes, Hyperlipidemia, and Metabolic-Associated Liver Disease: An Updated Overview of Clinical Implications;Current Treatment Options in Cardiovascular Medicine;2024-08-19

5. Six-month supplementation with high dose coenzyme Q10 improves liver steatosis, endothelial, vascular and myocardial function in patients with metabolic-dysfunction associated steatotic liver disease: a randomized double-blind, placebo-controlled trial;Cardiovascular Diabetology;2024-07-10